Structural Implications of Siglec-5-Mediated Sialoglycan Recognition

Journal of Molecular Biology

Volumn 375, Issue 2, 2008, Pages 437-447

  Zhuravleva, Marina A ^a   Trandem, Kathryn ^a   Sun, Peter D ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

carbohydrate specificity; Siglec 5 inhibitory receptor; two domain structure; (2,3) sialyllactose; (2,6) sialyllactose

Indexed keywords

CD33 ANTIGEN; GLYCEROL; SIALIC ACID DERIVATIVE; SIALIC ACID IMMUNOGLOBULIN LIKE BINDING LECTIN; SIALOGLYCOPROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BETA SHEET; CRYSTAL STRUCTURE; HYDROGEN BOND; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; STRUCTURAL HOMOLOGY; SURFACE PLASMON RESONANCE;

SIA;

EID: 36549003234     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.10.009     Document Type: Article

References (51)

1. Pusztai A., and Bardocz S. Lectins: biomedical perspectives (1995), Taylor & Francis, London, UK
2. Wong S.Y.C., and Arsequell G. Immunobiology of carbohydrates (2003), Landes Bioscience/Eurekah.com, Georgetown, TX
3. Caron M., and Sève A.-P. Lectins and pathology (2000), Harwood Academic, Amsterdam, The Netherlands
4. Gabius H.-J., and Gabius S. Lectins and cancer (1991), Springer-Verlag, Berlin, Germany
5. Sharon N., and Lis H. History of lectins: from hemagglutinins to biological recognition molecules. Glycobiology 14 (2004) 53R-62R
6. Sharon N., and Lis H. Lectins (1989), Chapman & Hall, London, UK
7. Crocker P.R., and Varki A. Siglecs, sialic acids and innate immunity. Trends Immunol. 22 (2001) 337-342
8. Varki A., and Angata T. Siglecs-the major subfamily of I-type lectins. Glycobiology 16 (2006) 1R-27R
9. Nitschke L., and Crocker P.R. The sialic acid-binding Siglec family. In: Wong S.Y.C., and Arsequell G. (Eds). Immunobiology of carbohydrates (2003), Landes Bioscience/Eurekah.com, Georgetown, TX 119-127
10. Crocker P.R., Paulson J.C., and Varki A. Siglecs and their roles in the immune system. Nat. Rev. Immunol. 7 (2007) 255-266
11. Angata T. Molecular diversity and evolution of the Siglec family of cell-surface lectins. Mol. Divers. 10 (2006) 555-566
12. Angata T., Hayakawa T., Yamanaka M., Varki A., and Nakamura M. Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates. FASEB J. 20 (2006) 1964-1973
13. Avril T., Freeman S.D., Attrill H., Clarke R.G., and Crocker P.R. Siglec-5 (CD170) can mediate inhibitory signaling in the absence of immunoreceptor tyrosine-based inhibitory motif phosphorylation. J. Biol. Chem. 280 (2005) 19843-19851
14. Crocker P.R. Siglecs in innate immunity. Curr. Opin. Pharmacol. 5 (2005) 431-437
15. Crocker P.R. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signaling. Curr. Opin. Struct. Biol. 12 (2002) 609-615
16. von Gunten S., and Simon H.-U. Sialic acid binding immunoglobulin-like lectins may regulate innate immune responses by modulating the life span of granulocytes. FASEB J. 20 (2006) 601-605
17. Nicoll G., Avril T., Lock K., Furukawa K., Bovin N., and Crocker P.R. Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms. Eur. J. Immunol. 33 (2003) 1642-1648
18. Connolly N.P., Jones M., and Watt S.M. Human Siglec-5: tissue distribution, novel isoforms and domain specificities for sialic acid-dependent ligand interactions. Br. J. Haematol. 119 (2002) 221-238
19. Virgo P., Denning-Kendall P.A., Erickson-Miller C.L., Singha S., Evely R., Hows J.M., and Freeman S.D. Identification of the CD33-related Siglec receptor, Siglec-5 (CD170), as a useful marker in both normal myelopoiesis and acute myeloid leukaemias. Br. J. Haematol. 123 (2003) 420-430
20. Nguyen D.H., Ball E.D., and Varki A. Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related Siglecs. Exp. Hematol. 34 (2006) 728-735
21. May A.P., Robinson R.C., Vinson M., Crocker P.R., and Jones E.Y. Crystal structure of the N-terminal domain of sialoadhesin in complex with 3′ sialyllactose at 1.85 Å resolution. Mol. Cell 1 (1998) 719-728
22. Alphey M.S., Attrill H., Crocker P.R., and Van Aalten D.M.F. High resolution crystal structures of Siglec-7. Insights into ligand specificity in the Siglec family. J. Biol. Chem. 278 (2003) 3372-3377
23. Yamaji T., Teranishi T., Alphey M.S., Crocker P.R., and Hashimoto Y. A small region of the natural killer cell receptor, Siglec-7, is responsible for its preferred binding to α2,8-disialyl and branched α2,6-sialyl residues. A comparison with Siglec-9. J. Biol. Chem. 277 (2002) 6324-6332
24. Dimasi N., Moretta A., Moretta L., Biassoni R., and Mariuzza R.A. Structure of the saccharide-binding domain of the human natural killer cell inhibitory receptor p75/AIRM1. Acta Crystallogr., Sect. D: Biol. Crystallogr. 60 (2004) 401-403
25. Attrill H., Takazawa H., Witt S., Kelm S., Isecke R., Brossmer R., et al. The structure of siglec-7 in complex with sialosides: leads for rational structure-based inhibitor design. Biochem. J. 397 (2006) 271-278
26. Cornish A.L., Freeman S., Forbes G., Ni J., Zhang M., Cepeda M., et al. Characterization of Siglec-5, a novel glycoprotein expressed on myeloid cells related to CD33. Blood 92 (1998) 2123-2132
27. Brinkman-Van der Linden E.C.M., and Varki A. New aspects of siglec binding specificities, including the significance of fucosylation and of the sialyl-Tn epitope. J. Biol. Chem. 275 (2000) 8625-8632
28. Blixt O., Collins B.E., van den Nieuwenhof I.M., Crocker P.R., and Paulson J.C. Sialoside specificity of the siglec family assessed using novel multivalent probes: identification of potent inhibitors of myelin-associated glycoprotein. J. Biol. Chem. 278 (2003) 31007-31019
29. Freeman S.D., Kelm S., Barber E.K., and Crocker P.R. Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules. Blood 85 (1995) 2005-2012
30. Angata T., and Varki A. Siglec-7: a sialic acid-binding lectin of the immunoglobulin superfamily. Glycobiology 10 (2000) 431-438
31. Zhang J.Q., Nicoll G., Jones C., and Crocker P. Siglec-9, a novel sialic acid binding member of the immunoglobulin superfamily expressed broadly on human blood leukocytes. J. Biol. Chem. 275 (2000) 22121-22126
32. Powell L.D., and Varki A. I-type lectins. J. Biol. Chem. 270 (1995) 14243-14246
33. Kelm S., Pelz A., Schauer R., Filbin M.T., Tang S., Bellard M.E., et al. Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily. Curr. Biol. 4 (1994) 965-972
34. Engel P., Norbert Wagner N., Miller A.S., and Tedder T.F. Identification of the ligand-binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand. J. Exp. Med. 181 (1995) 1581-1586
35. Attrill H., Imamura A., Sharma R.S., Kiso M., Crocker P.R., and Van Aalten D.M.F. Siglec-7 undergoes a major conformational change when complexed with the α2,8-disialylganglioside GT1b. J. Biol. Chem. 281 (2006) 32774-32783
36. Wang J.-H., Stehle T., Pepinsky B., Liu J.-H., Karpusas M., and Osborn L. Structure of a functional fragment of VCAM-1 refined at 1.9 Å resolution. Acta Crystallogr., Sect. D: Biol. Crystallogr. 52 (1996) 369-379
37. Snyder G.A., Brooks A.G., and Sun P.D. Crystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 3864-3869
38. Cantoni C., Ponassi M., Biassoni R., Conte R., Spallarossa A., Moretta A., et al. The three-dimensional structure of the human NK cell receptor NKp44, a triggering partner in natural cytotoxicity. Structure 11 (2003) 725-734
39. Radaev S., Rostro B., Brooks A.G., Colonna M., and Sun P.D. Conformational plasticity revealed by the cocrystal structure of NKG2D and its class I MHC-like ligand ULBP3. Immunity 15 (2001) 1039-1049
40. Radaev S., and Sun P.D. Crystallization of protein-protein complexes. Acta Crystallogr., Sect. D: Biol. Crystallogr. 35 (2002) 674-676
41. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276 (1997) 307-326
42. Navaza J. AMoRe: an automated package for molecular replacement. Acta Crystallogr., Sect. A: Found. Crystallogr. 50 (1994) 157-163
43. McCoy A.J., Grosse-Kunstleve R.W., Storoni L.C., and Read R.J. Likelihood-enhanced fast translation functions. Acta Crystallogr., Sect. D: Biol. Crystallogr. 61 (2005) 458-464
44. Kissinger C.R., Gehlhaar D.K., Smith B.A., and Bouzida D. Molecular replacement by evolutionary search. Acta Crystallogr., Sect. D: Biol. Crystallogr. 57 (2001) 1474-1479
45. Sun P.D., and Hammer C.H. Mass-spectrometry assisted heavy-atom derivative screening of human FcγRIII crystals. Acta Crystallogr., Sect. D: Biol. Crystallogr. 56 (2000) 161-168
46. Strokopytov B.V., Fedorov A., Mahoney N.M., Kessels M., Drubin D.G., and Almo S.C. Phased translation function revisited: structure solution of the cofilin-homology domain from yeast actin-binding protein 1 using six-dimensional searches. Acta Crystallogr., Sect. D: Biol. Crystallogr. 61 (2005) 285-293
47. Collaborative Computational Project, Number 4. The CCP4 Suite: programs for protein crystallography. Acta Crystallogr., Sect. D: Biol. Crystallogr. 50 (1994) 760-763
48. Jones T.A., Zou J.Y., Cowan S.W., and Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr., Sect. A: Found. Crystallogr. 47 (1991) 110-119
49. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., et al. Crystallography & NMR System: a new software suite for macromolecular structure determination. Acta Crystallogr., Sect. D: Biol. Crystallogr. 54 (1998) 905-921
50. Kleywegt G.J., and Jones T.A. Detecting folding motifs and similarities in protein structures. Methods Enzymol. 277 (1997) 525-545
51. DeLano W.L. The PyMOL Molecular Graphics System (2002), DeLano Scientific, San Carlos, CA